Li Bing, Wu Hong-Yan, Qian Xiao-Ping, Li Yan, Chen Wei-Feng
Immunology Department of Peking University Health Science Center, 38 Xueyuan Road, Beijing, 100083, China.
World J Gastroenterol. 2003 Apr;9(4):678-82. doi: 10.3748/wjg.v9.i4.678.
In order to assess hepatocellular carcinoma associated antigen HCA587 as a potential target for immunotherapy, the Bac-to-Bac expression system was used to express recombinant protein HCA587 in insect cells.
The cDNA encoding HCA587 gene was cloned into donor vector pFasBacHtb and recombinant pFasBac Htb-587 was transformed into competent cells DH10Bac. Recombinant Bacmid-587 was transfected into Sf9 insect cells using CELLFECTIN, Recombinant HCA587 protein was produced in Sf9 insect cells after infection with recombinant baculovirus, and was purified using Ni-NTA resin. Sera from HCC patients were also screened using recombinant protein HCA587.
The molecular weight of the recombinant protein HCA587 expressed in insect cells was approximately 43kd. Western blot results proved the recombinant protein HCA587 had the similar antigenicity with its native counterpart. Serological analysis told that the rate of seroreactivity to HCA587 was not high in HCC patients.
The recombinant protein HCA587 was successfully expressed and purified using Bac-to-Bac expression system. It paved the way for generation of specific antibody and investigation of immunohistochemical analysis and immune responses of HCC in the future.
为了评估肝细胞癌相关抗原HCA587作为免疫治疗的潜在靶点,采用杆状病毒表达系统在昆虫细胞中表达重组蛋白HCA587。
将编码HCA587基因的cDNA克隆到供体质粒pFasBacHtb中,将重组质粒pFasBac Htb-587转化到感受态细胞DH10Bac中。用CELLFECTIN将重组杆粒-587转染到Sf9昆虫细胞中,重组杆状病毒感染Sf9昆虫细胞后产生重组HCA587蛋白,并用Ni-NTA树脂进行纯化。还用重组蛋白HCA587筛选肝癌患者的血清。
在昆虫细胞中表达的重组蛋白HCA587的分子量约为43kd。蛋白质印迹结果证明重组蛋白HCA587与其天然对应物具有相似的抗原性。血清学分析表明,肝癌患者对HCA587的血清反应率不高。
利用杆状病毒表达系统成功表达并纯化了重组蛋白HCA587。为将来产生特异性抗体以及研究肝癌的免疫组化分析和免疫反应铺平了道路。